Pfizer reaffirmed $10–$15 billion for business development, with focus on immunology and cardiometabolic expansion. CEO Bourla says national security concerns are central to U.S. drug ...

Pfizer recently said it wouldn't continue development of its weight loss candidate danuglipron, a once-daily pill, after a patient in a clinical trial experienced liver injury -- the problem ...

Pfizer’s effective tax rate on Reported (2) income for the first quarter of 2025 is negative, primarily due to favorable global income tax resolutions in multiple tax jurisdictions spanning ...

Peoria Civic Center Arena Nov. 20 -- - Lincoln, Neb. @ Pinnacle Bank Arena Nov. 2 -- Oklahoma City, Okla. @ Paycom Center Green first announced his 2025 tour last September with a fast-paced ...

Pfizer Price Performance Shares of Pfizer stock opened at $22.95 on Friday. The company has a quick ratio of 0.73, a current ratio of 1.00 and a debt-to-equity ratio of 0.63. Pfizer has a 52 week ...

Pfizer's PFE non-COVID operational revenues improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and Eliquis, new launches and newly acquired products from Seagen. The trend ...

Australia Rod Laver Arena – March 26 Sydney, Australia Qudos Bank Arena – March 28 Sydney, Australia Qudos Bank Arena – March 29 Sydney, Australia Qudos Bank Arena – April 2 Auckland ...

The pop star is currently on her first major North American tour in 14 years, and had to scrap a date in the Mile High City due to a Nuggets game. Entertainment Weekly's Oscars expert, 'RuPaul's ...

Just one podcast wasn't enough for him, though. Arenas launched a second podcast, "Gil's Arena," in February 2023, and it has become one of the most popular shows around. The YouTube channel has ...

Pfizer recently made headlines with a strategic collaboration with Guardant Health, aimed at enhancing its oncology portfolio through advanced liquid biopsy technology. Simultaneously, the company ...

As Pfizer navigates these challenges, it faces rising competition from agile biotech firms wielding AI, gene editing, and mRNA technologies. By 2030, these innovators could surpass Pfizer’s drug ...

Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the sector, which pharma giant Pfizer privately warned could damage the Irish ...